Barbiturates and Benzodiazepines Notes

GABA_A Receptor Structure & Function

• Receptor Structure: Pentameric ligand-gated chloride channel typically composed of $2\alpha + 2\beta + 1\gamma$ subunits, accounting for approximately $30\%$ of brain synapses.

• Mechanism: Facilitates hyperpolarizing $\text{Cl}^-$ influx to decrease neuronal action potential firing.

• Subunit Heterogeneity & Function:

  • $\alpha1$: Located in cortex, striatum, and thalamus; mediates sedation and amnesia; highly sensitive to benzodiazepines and barbiturates.

  • $\alpha2$: Located in the limbic system; mediates anxiolysis; highly sensitive to benzodiazepines.

  • $\alpha3$: Located in the amygdala and hippocampus; mediates anxiolysis and muscle relaxation; sensitive to benzodiazepines.

  • $\alpha4$: Located in the thalamus and spinal cord; extrasynaptic location; low sensitivity to benzodiazepines.

  • $\alpha5$: Located in the hippocampus; mediates memory and learning (cognitive function); sensitive to benzodiazepines.

Key Differences Between Barbiturates and Benzodiazepines

• Binding Site: Barbiturates bind within the channel pore (at the $\beta\text{--}\gamma$ interface); benzodiazepines bind at the allosteric $\alpha\text{--}\gamma$ interface.

• Mechanism of Action: Barbiturates increase chloride channel opening duration and directly open the channel at high concentrations; benzodiazepines increase channel opening frequency and strictly require GABA.

• Subtype Selectivity: Barbiturates non-selectively affect all $\alpha$-subtypes; benzodiazepines show subtype selectivity ($\alpha1$, $\alpha2$, $\alpha3$, $\alpha5$).

• Therapeutic Index: Barbiturates have a narrow therapeutic index ($20\text{--}100\times$); benzodiazepines have a wide therapeutic index ($100\text{--}1000\times$).

• Overdose Management: Barbiturate overdose requires supportive care only (no antidote); benzodiazepine overdose can be managed with Flumazenil.

Barbiturates Overview

• Classification & Half-Lives:

  • Ultra-short ($15\text{--}40\,\text{min}$ duration, $T_{1/2} < 1\,\text{hour}$): Thiopental, Methohexital (IV anesthesia induction).

  • Short-acting ($3\text{--}4\,\text{hours}$ duration, $T_{1/2} = 15\text{--}40\,\text{min}$): Secobarbital, Pentobarbital (insomnia, pre-op sedation).

  • Intermediate ($4\text{--}6\,\text{hours}$ duration, $T_{1/2} = 4\text{--}6\,\text{hours}$): Butabarbital, Amobarbital (insomnia, sedation).

  • Long-acting ($24+\text{hours}$ duration, $T_{1/2} = 24\text{--}48\,\text{hours}$): Phenobarbital, Mephobarbital (seizure disorders, chronic use).

• Clinical Indications: Phenobarbital controls $80\text{--}85\%$ of seizures at therapeutic blood levels of $15\text{--}40\,\mu\text{g/mL}$ (toxicity occurs above $50\,\mu\text{g/mL}$).

• Metabolism & Toxicity:

  • Induces hepatic enzymes (CYP2C9, CYP2C19, CYP3A4), enhancing metabolism of drugs like Warfarin, Phenytoin, oral contraceptives, and corticosteroids.

  • Contraindicated in Acute Intermittent Porphyria (AIP) due to ALA synthase induction.

Benzodiazepines Overview

• Classification & Half-Lives:

  • Ultra-short ($T_{1/2} = 1\text{--}4\,\text{hours}$): Midazolam, Triazolam.

  • Short-acting ($T_{1/2} = 6\text{--}12\,\text{hours}$): Oxazepam, Lorazepam, Alprazolam.

  • Long-acting ($T_{1/2} = 24\text{--}48+\text{hours}$): Diazepam, Chlordiazepoxide, Flurazepam.

• Metabolic Metabolism Pathways:

  • Oxidized agents (e.g., Diazepam) form long-acting active metabolites such as Desmethyldiazepam ($T_{1/2} = 48\text{--}96\,\text{hours}$).

  • Glucuronidated agents (Lorazepam, Oxazepam) bypass Phase I oxidation, forming no active metabolites, making them safer for elderly patients and liver disease.

• Clinical Indications:

  • Seizure Emergencies: IV Lorazepam ($4\,\text{mg}$) is first-line for status epilepticus.

  • Alcohol Withdrawal: Managed with Lorazepam, Diazepam, or Chlordiazepoxide titrated via CIWA-Ar scale.

• Adverse Effects & Reversal:

  • Black Box Warning: Co-administration with opioids causes severe respiratory depression and accounts for $\sim 30\%$ of opioid overdose deaths.

  • Elderly Risk: Per Beers Criteria, avoid due to a $1.4\text{--}1.8\times$ increased fall risk and $1.5\text{--}2\times$ increased hip fracture risk.

  • Antidote: Flumazenil ($0.2\,\text{mg}$ IV) acts as a competitive antagonist, but carries a $10\text{--}15\%$ seizure risk in chronic users.